Full access
Government News
Published Online: 3 January 2003

Federal Office Gives Psychiatrist Key Addiction-Research Post

Eve BenderAuthors Info & Affiliations
Publication: Psychiatric News
Volume 38, Number 1
https://doi.org/10.1176/pn.38.1.0004a
Track CitationsAdd to favorites
PDF/EPUB
The White House Office of National Drug Control Policy (ONDCP) Counterdrug Technology Assessment Center (CTAC) has chosen an APA member as one of the recipients of a $5.85 million grant to investigate the genetic factors that predispose people to addiction.
Patricia Ordorica, M.D., is associate chief of staff for mental health and behavioral sciences at the James A. Haley VA Hospital in Tampa and clinical director of the CTAC Drug Addiction Study. She is also the director of addictive disorders and associate professor of psychiatry at the University of South Florida in Tampa.
In APA, Ordorica is chair of the APA/CMHS Minority Fellowship Selection and Advisory Committee, vice chair of APA’s Scientific Program Committee, and a member of the Vestermark Award Corresponding Committee.
As clinical director of the study, Patricia Ordorica, M.D., will oversee all administrative and clinical aspects of the drug addiction treatment research, and with principal investigator Michael Mullan, M.D., Ph.D., supervise the research components and operations. Mullan is director of the Roskamp Institute, a research facility in Tampa.
Patients with substance use disorders will be recruited from the veterans hospital and other CTAC-funded research centers in a sample that will top 1,000 patients. The research team will use the ONDCP funding to purchase the latest gene chip and protein analysis technology, which will enable them to study hundreds of thousands of human genes and the proteins expressed by those genes.
By identifying the genes and proteins activated by different drugs of abuse, the researchers hope to design a therapeutic intervention that will ultimately disrupt the addiction process. ▪

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 38 • Number 1 • January 3, 2003
Pages: 4

History

Published online: 3 January 2003
Published in print: January 3, 2003

Notes

The White House Office of National Drug Control Policy is funding cutting-edge gene and protein analysis technology to search for the molecular causes of addiction.

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.